Literature DB >> 33604328

Computational Prediction of Hot Spots and Binding Site of Inhibitor NSC23766 on Rac1 Binding With Tiam1.

Chunwen Zheng1, Xiaodong Wu2,3, Ruijie Zeng1, Lirui Lin2,3, Liyan Xu4, Enmin Li2,4, Geng Dong2,3.   

Abstract

Rac1 is a small signaling protein, which belongs to the Rho subfamily of Ras superfamily. It is activated by binding GTP and inactivated by exchanging GDP for GTP. The ability of nucleotide exchange depends on guanine nucleotide exchange factors (GEFs) family proteins. T-lymphoma invasion and metastasis factor 1 (Tiam1) is a member of GEFs. Rac1 participates in multiple signaling pathways and regulates various cellular events by interacting with GEFs. Particularly, it is involved in the development and progression of various kinds of tumors. In this paper, we have studied the detailed interaction between Rac1 and Tiam1. Seven residues on Rac1 are predicted to be important for the interaction with Tiam1, i.e. E31, Y32, D38, N39, Y64, D65 and W56. All these residues are located on the switch 1 and 2 domains which are the interface between Rac1 and Tiam1, except W56. In addition, we analyzed how inhibitor NSC23766 interacts with Rac1. Our docking results show that NSC23766 binds to the same region as Tiam1. Several residues, i.e. F37, D38, N39, W56, Y64, L67, L70 and S71, contribute much to binding free energy. These findings are very useful for the structure-based design of inhibitors toward Rac1.
Copyright © 2021 Zheng, Wu, Zeng, Lin, Xu, Li and Dong.

Entities:  

Keywords:  MD simulation; NSC23766; Rac1; Tiam1; binding free energy; molecular docking

Year:  2021        PMID: 33604328      PMCID: PMC7884829          DOI: 10.3389/fchem.2020.625437

Source DB:  PubMed          Journal:  Front Chem        ISSN: 2296-2646            Impact factor:   5.221


  43 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Fast, efficient generation of high-quality atomic charges. AM1-BCC model: II. Parameterization and validation.

Authors:  Araz Jakalian; David B Jack; Christopher I Bayly
Journal:  J Comput Chem       Date:  2002-12       Impact factor: 3.376

3.  Rational design and characterization of a Rac GTPase-specific small molecule inhibitor.

Authors:  Yuan Gao; J Bradley Dickerson; Fukun Guo; Jie Zheng; Yi Zheng
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-05       Impact factor: 11.205

4.  Development and testing of a general amber force field.

Authors:  Junmei Wang; Romain M Wolf; James W Caldwell; Peter A Kollman; David A Case
Journal:  J Comput Chem       Date:  2004-07-15       Impact factor: 3.376

5.  Critical off-target effects of the widely used Rac1 inhibitors NSC23766 and EHT1864 in mouse platelets.

Authors:  S Dütting; J Heidenreich; D Cherpokova; E Amin; S-C Zhang; M R Ahmadian; C Brakebusch; B Nieswandt
Journal:  J Thromb Haemost       Date:  2015-02-23       Impact factor: 5.824

6.  Increased Rac1 activity and Pak1 overexpression are associated with lymphovascular invasion and lymph node metastasis of upper urinary tract cancer.

Authors:  Takao Kamai; Hiromichi Shirataki; Kimihiro Nakanishi; Nobutaka Furuya; Tsunehito Kambara; Hideyuki Abe; Tetsunari Oyama; Ken-Ichiro Yoshida
Journal:  BMC Cancer       Date:  2010-04-28       Impact factor: 4.430

Review 7.  Rho GTPases as therapeutic targets in cancer (Review).

Authors:  G A Cardama; N Gonzalez; J Maggio; P Lorenzano Menna; D E Gomez
Journal:  Int J Oncol       Date:  2017-08-09       Impact factor: 5.650

8.  RhoA regulates resistance to irinotecan by regulating membrane transporter and apoptosis signaling in colorectal cancer.

Authors:  Huang Ruihua; Zhang Mengyi; Zhao Chong; Qiu Meng; Ma Xin; Tang Qiulin; Bi Feng; Liu Ming
Journal:  Oncotarget       Date:  2016-12-27

9.  Reduced expression of small GTPases and hypermethylation of the folate binding protein gene in cisplatin-resistant cells.

Authors:  D-W Shen; A Su; X-J Liang; A Pai-Panandiker; M M Gottesman
Journal:  Br J Cancer       Date:  2004-07-19       Impact factor: 7.640

10.  AMDock: a versatile graphical tool for assisting molecular docking with Autodock Vina and Autodock4.

Authors:  Mario S Valdés-Tresanco; Mario E Valdés-Tresanco; Pedro A Valiente; Ernesto Moreno
Journal:  Biol Direct       Date:  2020-09-16       Impact factor: 4.540

View more
  5 in total

1.  Pharmacological inhibition of Rac1 attenuates myocardial abnormalities in tail-suspended mice.

Authors:  Huili Li; Ting Cao; Weimin Ding; Liwen Liang; Guo-Chang Fan; Lina Qu; Tianqing Peng
Journal:  J Cardiovasc Transl Res       Date:  2022-01-28       Impact factor: 4.132

2.  Identification of potent and novel inhibitors against RAC1: a Rho family GTPase.

Authors:  Geet Madhukar; Naidu Subbarao
Journal:  In Silico Pharmacol       Date:  2022-08-01

Review 3.  Rac1 as a Target to Treat Dysfunctions and Cancer of the Bladder.

Authors:  Vincent Sauzeau; Julien Beignet; Christian Bailly
Journal:  Biomedicines       Date:  2022-06-08

4.  Bioinformatics-Guided Identification of Ethyl Acetate Extract of Citri Reticulatae Pericarpium as a Functional Food Ingredient with Anti-Inflammatory Potential.

Authors:  Enyao Ma; Lu Jin; Chunguo Qian; Chong Feng; Zhimin Zhao; Hongru Tian; Depo Yang
Journal:  Molecules       Date:  2022-08-25       Impact factor: 4.927

Review 5.  Rac1, A Potential Target for Tumor Therapy.

Authors:  Jiaxin Liang; Linda Oyang; Shan Rao; Yaqian Han; Xia Luo; Pin Yi; Jinguan Lin; Longzheng Xia; Jiaqi Hu; Shiming Tan; Lu Tang; Qing Pan; Yanyan Tang; Yujuan Zhou; Qianjin Liao
Journal:  Front Oncol       Date:  2021-05-17       Impact factor: 6.244

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.